Call Us Today:
949.200.1600

Adnexal Carcinoma

Home > Diagnosis > Squamous Cell Carcinoma > Adnexal Carcinoma

Treatment for Microcystic Adnexal Carcinoma

ABOUT ADNEXAL CARCINOMA

In general, adenocarcinomas of skin, when diagnosed, must be differentiated from metastasis of a visceral adenocarcinoma to the skin. PET scan plays an important role in that setting. The most common adenocarcinoma of the skin is the cutaneous adnexal eccrine (sweat gland) carcinoma. Within the category of adnexal eccrine carcinomas, the most common include microcystic adnexal carcinoma (MAC), eccrine porocarcinoma, and hidradenocarcinoma. Less common subtypes are eccrine mucinous carcinoma, malignant eccrine spiradenoma, malignant mixed tumor, malignant cylindroma, and digital papillary eccrine adenoma.

 

Eccrine (sweat gland) porocarcinoma has a metastatic potential and a significant recurrence rate. MAC (microcystic adnexal carcinoma) is a locally aggressive tumor tending to have a wider subclinical spread than its obvious benign appearing surface lesion. Because of this silent spread, Mohs micrographic surgery often uncovers an extensive spread not appreciated prior to surgery. The good news is that it only has a rare metastatic potential, although it still carries a higher local recurrence rate than most other skin cancers.

 

Histologic grade of an adenocarcinoma is the most important factor in predicting its behavior. Higher grade tumors require combination therapy – primarily surgery and radiation. Surgery can be either wide local resection or Mohs micrographic surgery. Chemotherapy is an adjunct in the setting of bulky or unresectable disease.

Related Articles

Management of Invasive Squamous Cell Carcinoma Arising in Bowen’s Disease
A patient presented to the SCARS Center with a nine month history of a biopsy proven Bowen’s disease of the left second toe. Mohs surgery discovered areas of invasive squamous cell carcinoma arising from Bowen’s disease within the lesion. After completing Mohs surgery, additional deep soft tissue and phalanx bone were resected to insure tumor…
Read More
Treatment Considerations for Melanoma In-Situ
HISTORY A 22-year-old woman presented with left upper lip lesion. Tape testing showed positive for LINC00518 and PRAME. Excisional biopsy was performed showing atypia on the preliminary results. DISCUSSION Management of melanoma in-situ can be especially challenging in cosmetically sensitive areas such as the lip. Traditional management options for melanoma in-situ include surgical excision, topical…
Read More
Management of Non-Healing Lesion
HISTORY An 85-year-old man with a history of multiple BCC and SCC of the scalp previously treated with radiation and intralesional 5-FU presents with a non healing lesion of the left parietal scalp. Shave biopsy of the left parietal scalp performed on 7/21/21 showed a non specific ulcer with atypical squamous epithelium of the scalp.…
Read More
Managing Eyelid Skin Cancer
HISTORY A 53-year-old man presented with an approximately 10-year history of right upper eyelid “psoriasis.” He was treated with alclometasone dipropionate 0.05% ointment which helped with redness but flaking was still present. Trial of Protopic 0.1% ointment on 1/23/20 with minimal relief. Punch biopsy of the right upper eyelid on 5/19/21 showed inflamed AK. Area…
Read More
Managing Lentigo Maligna Melanoma
HISTORY A 56-year-old man presented with complaint of lifelong history of darkening, growing left lesion of the left cheek. Biopsy on 09/24/21 showed melanoma in-situ. Excision with 5-6mm margins and closure of left cheek melanoma performed on 12/2/21 showed positive margins at 3-4 o’clock margins. Woods lamp evaluation and re-excision performed on 1/7/22. DISCUSSION Lentigo…
Read More
A Modern Test for Melanoma
DecisionDx Melanoma is enhancing medical decision making in invasive melanoma stages I, II, and III.. Management of cutaneous melanoma involves strategic risk assessment and oncologic work-up. This typically includes staging, wide local excision, and possible sentinel lymph node biopsy or biologic therapy.  Traditionally, surgeons perform a sentinel lymph node biopsy (SLNB) if the possibility of…
Read More

STAY UP TO DATE

Receive research updates, inspiring stories, healthy living tips and more.

Something went wrong. Please check your entries and try again.

FOLLOW US

ELEVATING THE STANDARDS OF SKIN CANCER MANAGEMENT.

© 2018 SCARS Management Services. All rights reserved.